Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
ZSK Attorneys-at-Law provides ‘expert guidance’ to domestic and multinational clients in the life sciences and healthcare industry, including assistance with licensing agreements, anti-corruption policies, and building compliance systems. Yue Peng directs the group, bringing a wealth of experience advising pharmaceutical and biotech companies on commercialisation, clinical trials, and financing transactions.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
- 'ZSK Attorneys-at-Law provides expert guidance on a range of matters, including compliance with our China-specific business model, anti-corruption policies, R&D collaborations within the country, sales initiatives, licensing agreements, and other related issues. ZSK is very good at dealing with problems in the field of healthcare, which is why we choose ZSK.''
- 'ZSK has extensive experience and unique insight in the healthcare field, with a focus on compliance in cross-border transactions. They are able to deeply understand our needs, maintain efficient communication, continuously improve transaction documents and carefully handle every aspect of the transaction to achieve excellence.'
Clients clés
- ChemPartner PharmaTech Co., Ltd.
- Jiangsu Ascentage Pharma Development Co., Ltd.
Points forts
- Advised InxMed on license in of Shi Jian's ADC technology platform EZWi-Fit for the development of ADC products targeting InxMed's biotargets.
- Advised Nanjing Bio-tech and Pharmaceutical Valley on setting up three medical funds.